Verve Therapeutics Inc (VERV)
5.27
-0.15
(-2.77%)
USD |
NASDAQ |
Jun 17, 16:00
5.275
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Market Cap: 442.50M for June 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 17, 2024 | 442.50M |
| June 14, 2024 | 455.09M |
| June 13, 2024 | 470.21M |
| June 12, 2024 | 469.37M |
| June 11, 2024 | 447.54M |
| June 10, 2024 | 450.06M |
| June 07, 2024 | 437.46M |
| June 06, 2024 | 443.34M |
| June 05, 2024 | 448.38M |
| June 04, 2024 | 444.18M |
| June 03, 2024 | 440.82M |
| May 31, 2024 | 435.78M |
| May 30, 2024 | 431.58M |
| May 29, 2024 | 426.54M |
| May 28, 2024 | 439.98M |
| May 24, 2024 | 443.34M |
| May 23, 2024 | 447.54M |
| May 22, 2024 | 470.21M |
| May 21, 2024 | 465.17M |
| May 20, 2024 | 499.59M |
| May 17, 2024 | 502.11M |
| May 16, 2024 | 535.70M |
| May 15, 2024 | 523.11M |
| May 14, 2024 | 523.11M |
| May 13, 2024 | 522.27M |
| Date | Value |
|---|---|
| May 10, 2024 | 504.63M |
| May 09, 2024 | 534.02M |
| May 08, 2024 | 510.51M |
| May 07, 2024 | 517.23M |
| May 06, 2024 | 538.22M |
| May 03, 2024 | 538.22M |
| May 02, 2024 | 516.39M |
| May 01, 2024 | 503.54M |
| April 30, 2024 | 504.38M |
| April 29, 2024 | 525.36M |
| April 26, 2024 | 516.96M |
| April 25, 2024 | 522.00M |
| April 24, 2024 | 552.21M |
| April 23, 2024 | 577.39M |
| April 22, 2024 | 579.91M |
| April 19, 2024 | 557.25M |
| April 18, 2024 | 558.93M |
| April 17, 2024 | 565.64M |
| April 16, 2024 | 599.21M |
| April 15, 2024 | 613.48M |
| April 12, 2024 | 637.81M |
| April 11, 2024 | 677.26M |
| April 10, 2024 | 671.40M |
| April 09, 2024 | 733.42M |
| April 08, 2024 | 704.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
426.54M
Minimum
May 29 2024
3.551B
Maximum
Sep 10 2021
1.373B
Average
1.177B
Median
Dec 22 2022
Market Cap Benchmarks
| Acorda Therapeutics Inc | 0.3043M |
| Eli Lilly and Co | 841.12B |
| Gritstone Bio Inc | 82.60M |
| Beam Therapeutics Inc | 1.978B |
| Prime Medicine Inc | 762.20M |
Market Cap Related Metrics
| PS Ratio | 23.83 |
| Price to Book Value | 0.7589 |
| Price | 5.27 |
| Earnings Yield | -54.46% |